View in EDS

A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure.

Saved in:

Bibliographic Details
Title:	A phase I/II trial of Erlotinib in higher risk myelodysplastic syndromes and acute myeloid leukemia after azacitidine failure.
Authors:	Thepot, Sylvain¹, Boehrer, Simone², Seegers, Valérie³, Prebet, Thomas⁴, Beyne-Rauzy, Odile⁵, Wattel, Eric⁶, Delaunay, Jacques⁷, Raffoux, Emmanuel⁸, Hunault, Mathilde¹, Jourdan, Eric⁹, Chermat, Fatiha¹⁰, Sebert, Marie¹⁰, Kroemer, Guido¹¹, Fenaux, Pierre¹⁰, Adès, Lionel¹⁰ lionel.ades@avc.aphp.fr
Source:	Leukemia Research. Dec2014, Vol. 38 Issue 12, p1430-1434. 5p.
Database:	Academic Search Ultimate

Description
ISSN:	01452126
DOI:	10.1016/j.leukres.2014.09.014